림프부종 환자에서 림프신티그라피의 임상적 적용

서민석¹^,^*

Clinical Application of Lymphoscintigraphy in Lymphedema

Minseok Suh¹^,^*

¹서울대학교 의과대학 핵의학교실

¹Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul Republic of Korea

^*Address for correspondence: Minseok Suh, MD, PhD, Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea, Tel: +82-2-2072-2534, Fax: +82-2-745-7690, E-mail: mandu3710@gmail.com

ⓒ Copyright 2026 Korean Society of Lymphology and Lymphedema. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Mar 08, 2022; Accepted: Apr 01, 2022

Published Online: May 31, 2022

Abatract

Lymphoscintigraphy is a non-invasive imaging test that visualizes the functions of the lymphatic system by injecting a colloidal radiopharmaceutical having a relatively large particle size (15-100 nm) intradermally or subcutaneously. For lymphedema occurring after cancer treatment lymphoscintigraphy can be applied in 1) differential diagnosis of edema, 2) visualize the functional status and severity of the lymphedema in a qualitative and quantitative manner, 3) evaluate functional improvement of lymphatics after treatment, 4) predict and may guide the therapeutic effect of lymphedema treatment. In this review, we will introduce clinical application studies according to the indications of lymphoscintigraphy and discuss the technical considerations of lymphoscintigraphy.

Keywords: Lymphoscintigraphy; Lymphedema; Prognosis; Complex Decongestive Physical Therapy; Lymphaticovenular Anastomosis